05:12 PM EDT, 05/07/2024 (MT Newswires) -- Richard A Miller, Director, President and CEO, on May 06, 2024, executed a purchase for 577,634 shares in Corvus Pharmaceuticals ( CRVS ) for $1,000,000. Following the Form 4 filing with the SEC, Miller has control over a total of 2,067,753 shares of the company, with 577,634 shares held directly and 1,490,119 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1626971/000161071724000231/xslF345X03/form4.xml

Price: 1.8100, Change: +0.13, Percent Change: +7.74